RBAKDN

Across TCGA pan-cancer cohorts, RBAKDN RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RBAKDN data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RBAKDN RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBAKDN expression acts as an unfavorable survival marker, although some lineages such as PAAD and CHOL show a favorable association.

KIRC, UVM, and ACC are the cancer types where RBAKDN RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	All	0.710	0.830	<.001	129	view →
UVM	OS	Median	All	0.729	0.958	<.001	98	view →
ACC	DFS	Quartile	All	0.284	0.700	<.001	83	view →
OV	OS	Quartile	All	0.622	0.774	.001	76	view →
CESC	DFS	Median	All	0.761	0.883	<.001	64	view →
COAD	OS	Median	All	0.502	0.740	<.001	55	view →
UCS	OS	Median	All	0.541	0.798	<.001	52	view →
UCEC	DFS	Median	III,IV	0.468	0.664	.012	52	view →
PAAD	OS	Median	All	0.493	0.286	.001	32	view →
LGG	DFS	Tertile	All	0.643	0.802	<.001	29	view →
CHOL	OS	Quartile	II,III,IV	0.996	0.238	.008	27	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	26	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RBAKDN–KIRC (DFS)

Open the KIRC breakdown →